Fluoxetine-induced anxiety and nervousness

Pharmacological Reports

Volumn 58, Issue 1, 2006, Pages 115-119

  Zienowicz, Małgorzata ^a   Wisłowska Stanek, Aleksandra ^a   Lehner, Małgorzata ^b   Taracha, Ewa ^b   Maciejak, Piotr ^a,b   Sobolewska, Alicja ^b   Szyndler, Janusz ^a   Turzyńska, Danuta ^b   Walkowiak, Jerzy ^b   Płaźnik, Adam ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Anxiety; Fluoxetine; Open field; Pentetrazole; Pharmacokinetics; Rat

Indexed keywords

FLUOXETINE; PENTETRAZOLE; SEROTONIN 2C RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; AROUSAL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG ABSORPTION; DRUG BRAIN LEVEL; DRUG DOSE REGIMEN; DYSPHORIA; EMOTION; EXPLORATORY BEHAVIOR; MALE; NEOPHOBIA; NERVOUSNESS; NONHUMAN; OPEN FIELD TEST; RAT; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION;

EID: 33646172578     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S: Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A antagonist WAY-100635. Int J Neuropsychopharmacol, 2001, 4, 399-408.
2. Beasley CM, Potvin JH: Fluoxetine: activating and sedating effects. Int Clin Psychopharmacol, 1993, 8, 271-275.
3. Bristow LJ, O'Connor D, Watts R, Duxon MS, Hutson PH: Evidence for accelerated desensitization of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat. Neuropharmacol, 2000, 39, 1222-1236.
4. Chen Y, Peng L, Zhang X, Stolzenburg JU, Hertz L: Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells. Brain Res Bull, 1995, 38, 153-159.
5. FDA Proposed Medication Guide: About Using Antide-pressants in Children or Teenagers, http://www.fda.gov/ceder/drug/antidepressants/default.htm
6. Gram L: Fluoxetine. N Eng J Med, 1994, 331, 1354-1361.
7. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C: Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron, 2002, 34, 30-356.
8. Jick H, Kaye JA, Jick SS: Antidepressants and the risk of suicidal behaviors. JAMA, 2004, 292, 338-381.
9. Jones N, Duxon MS, King SM: Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents. Psychopharmacology, 2002, 161, 314-323.
10. Leonard BE: Evidence for a biochemical lesion in depression. J Clin Psychiatry, 2000, 61, Suppl 6, 12-17.
11. Owens JM, Knight DL, Nemeroff CB: Second generation SSRI: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Encephale, 2002, 28, 335-55.
12. Ramzan IM, Levy G: Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid at onset of convulsions. J Pharmacol Exp Ther, 1985, 234, 624-628.
13. 3[H]-epibatidine. Pol J Pharmacol, 2003, 55, 17-23.
14. Sienkiewicz-Jarosz H, Maciejak P, Krzaścik P, Członkowska Al, Szyndler J, Bidziński A, Kostowski W, Płaźnik A: The effects of administration of physostigmine in two models of anxiety. Pharmacol Biochem Behav, 2003, 75, 491-496.
15. Treit D, Fundytus M: Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav, 1988, 31, 959-962.
16. Vasvani M, Linda FK, Ramesh S: Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27, 85-102.
17. Walsh MT, Dinan TG: Selective serotonin reuptake inhibitor and violence: a review of the available evidence. Acta Psychiatrica Scand, 2001, 104, 84-91.
18. Zhang X, Peng L, Chen Y, Hertz L: Stimulation of glycogenolysis in astrocytes by fluoxetine, and antidepressant acting like 5-HT. Neuroreport, 1993, 10, 1253-1258.
19. Zienowicz M, Wisłowska A, Lehner M, Taracha E, Skórzewska A, Maciejak P, Płaźnik A: The effect of fluoxetine in a model of chemically induced seizures - behavioral and immunocytochemical study. Neurosci Lett, 2004, 373, 226-231.